Related Experiment Video
Updated: Jan 24, 2026

Use of a Monocyte Monolayer Assay to Evaluate Fcγ Receptor-mediated Phagocytosis
Published on: January 2, 2017
Does cancer cell-expressed SLAMF7 impact on CD47-mediated phagocytosis?
Renee Bouwstra1, Tom van Meerten1, Edwin Bremer1
1Department of Hematology, University of Groningen, University Medical Center Groningen (UMCG), Groningen, The Netherlands.
Abstract:
Innate immune checkpoint CD47 has emerged as a prominent target for cancer immunotherapy and defining biomarkers predictive of response will be a crucial step towards clinical implementation. Hereto, we investigated the importance of a previously reported requisite for SLAM family member 7(SLAMF7) expression on cancer cell phagocytosis for effective CD47 antibody therapy.
Insights
SLAMF7 expression on cancer cells is crucial for effective CD47 antibody immunotherapy. This finding helps identify biomarkers to predict patient response to cancer treatments targeting the CD47 immune checkpoint.
Area of Science:
- Immunology
- Oncology
- Cancer Immunotherapy
Background:
- The innate immune checkpoint CD47 is a key target in cancer immunotherapy.
- Biomarkers predicting response are essential for clinical application of CD47-targeting therapies.
Purpose of the Study:
- To investigate the role of Signaling Adaptor Molecule 7 (SLAMF7) expression in cancer cells for effective CD47 antibody therapy.
- To determine if SLAMF7 is a requisite for cancer cell phagocytosis in CD47-targeted treatment.
Main Methods:
- Investigated the necessity of SLAMF7 expression on cancer cells.
- Assessed the impact of SLAMF7 on cancer cell phagocytosis.
- Evaluated the efficacy of CD47 antibody therapy in relation to SLAMF7.
Main Results:
- SLAMF7 expression was found to be a critical factor for cancer cell phagocytosis.
- The presence of SLAMF7 on cancer cells is important for the effectiveness of CD47 antibody therapy.
Conclusions:
- SLAMF7 expression is a key determinant of response to CD47 antibody therapy.
- SLAMF7 may serve as a predictive biomarker for patients undergoing CD47-targeted cancer immunotherapy.
More Related Videos
05:21Author Spotlight: Optimizing Antibody-Based Cancer Treatments via Antibody-Dependent, Cell-Mediated Cytotoxicity Assay
Published on: September 13, 2024
08:13Mitigation of Blood Borne Cell Attachment to Metal Implants through CD47-Derived Peptide Immobilization
Published on: December 3, 2020
Related Concept Videos
Phagocytosis
Phagocytosis
The objective of phagocytosis is often destruction. Cells use phagocytosis to eliminate unwelcome visitors, like pathogens (e.g., viruses and bacteria). Many immune system cells,...
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized...
Impact of Groups on Groups
Cell Specific Gene Expression
Impact
When particles with different initial velocities collide, they induce deformation by applying equal and opposite impulses. At the point of maximum deformation, the particles move together with...